Showing results (1711-1720 of 2,048) with videos related to

Sort By:
Pageof 205
Blood Advances|August 2, 2023
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 studyStephen M Ansell, Paul J Bröckelmann, Gottfried von Keudell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2023
Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-UpAndrew J Davies, Sharon Barrans, Louise Stanton, et al.
Mathematical Biosciences|June 3, 2023
Challenges in cybersecurity: Lessons from biological defense systemsEdward Schrom, Ann Kinzig, Stephanie Forrest, et al.
JAMA Network Open|February 21, 2022
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19Csilla Várnai, Claire Palles, Roland Arnold, et al.
The American Journal of Cardiology|August 6, 2022
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)Beth A Davison, Koji Takagi, Christopher Edwards, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
Pageof 205